ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Rhode Island » Internal Medicine

Top Internal Medicine Prescribers in Rhode Island

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CHRISTOPHER SUPERCZYNSKI M.D.

Internal Medicine

21,901

$981K

1024
858 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $51

HUGO YAMADA MD

Internal Medicine

16,238

$1.03M

593
495 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $51

DAVID FRIED MD

Internal Medicine

10,740

$610K

408
369 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $51

EDSELL BERNARDO M.D.

Internal Medicine

11,897

$591K

475
424 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $51

R GILLIE MD

Internal Medicine

9,249

$439K

389
359 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $51

JASON BOUDJOUK M.D.

Internal Medicine

14,931

$780K

385
339 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $51

PETER ELLER M.D.

Internal Medicine

13,597

$677K

624
558 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $51

STEPHANIE KRUSZ MD

Internal Medicine

11,795

$497K

476
379 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $51

RICHARD RUGGIERI M.D.

Internal Medicine

34,402

$1.78M

1113
901 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $51

GREGORY ALLEN D.O.

Internal Medicine

18,922

$1.05M

484
330 are 65+

14%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

AMBER GUL M.D.

Internal Medicine

8,094

$367K

380
304 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $51

SUMAIRA ALI M.D.

Internal Medicine

5,904

$308K

331
270 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $51

OLGA TVERSKAYA M.D.

Internal Medicine

14,018

$789K

457
364 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

JOHN BANDOLA M.D.

Internal Medicine

15,752

$725K

560
521 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $51

JOAN HARRISON M.D.

Internal Medicine

11,908

$509K

417
331 are 65+

17%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$43
Average prescription price

Avg: $51

PAMELA HARROP MD

Internal Medicine

16,065

$690K

479
438 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$43
Average prescription price

Avg: $51

FADI MANSOURATI MD

Internal Medicine

7,877

$654K

267
210 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 7%

N/A

24%
prescriptions for brand name drugs

Avg: 22%

$83
Average prescription price

Avg: $51

ALLEN DENNISON M.D.

Internal Medicine

9,933

$644K

460
399 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $51

FRANCISCO GUTIERREZ M.D.

Internal Medicine

11,477

$616K

386
318 are 65+

17%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $51

ROBERT CICCHELLI MD

Internal Medicine

10,394

$532K

425
369 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $51

FARHAT IBRAHIM M.D.

Internal Medicine

10,032

$403K

373
321 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $51

LEONARD MANNARELLI D.O.

Internal Medicine

14,299

$784K

407
240 are 65+

16%
patients receiving schedule two controlled substances

Avg: 4%

20%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

ANTIOAN KARDOUS MD

Internal Medicine

11,620

$519K

309
250 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $51

JIBRAN KHAN M.D.

Internal Medicine

8,162

$420K

272
139 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $51

WILLIAM BELIVEAU MD

Internal Medicine

17,678

$867K

675
600 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank